Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Pediatric Rheumatology
Do you routinely pursue cardiac evaluation in children presenting with post-streptococcal reactive arthritis given the diagnostic overlap with acute rheumatic fever?
Related Questions
How would you treat suspected secondary HLH in patients whom etoposide is contraindicated?
How do you discuss sexual health with pediatric patients transitioning to adult rheumatology care when the patient is accompanied by parents or caregiver?
Would you consider combination belimumab and anakinra for a patient who has SLE and MAS?
In patients with possible early SLE or undifferentiated disease can multiomics be used to help predict what disease phenotype they will develop?
In a patient with SJIA who has been stable on Anakinra however is now planning to conceive or becomes pregnant, would you consider switching to Cimzia?
Do you recommend genetic screening for FMF in asymptomatic first-degree relatives with a strong family history (multiple family members, severe/refractory disease)?
Do you always pursue testing for NOD2 mutations when you are suspecting a diagnosis of Blau syndrome?
How would you approach management of a patient with sJIA that was previously well controlled on tocilizumab but is now having ongoing joint disease activity?
How do you treat MAS in patients with systemic JIA or AOSD with HLA-DRB1*15 alleles given risk for DRESS hypersensitivity to IL1 or IL6 inhibitor therapy?
What are some of the biggest challenges you run into when patients transition from pediatric to adult care?
